Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$874,651
-$70,836 QoQ
Shares Held
6,923
+1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,134
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Analysts, LLC holds $29,659,281 across 14 Drug Manufacturers - General names. GILD ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
72,378 | $9,300,573 | |
| 2 | JNJ |
Johnson & Johnson
|
32,347 | $8,215,167 | |
| 3 | LLY |
ELI LILLY & Co
|
5,315 | $6,374,970 | |
| 4 | ABBV |
AbbVie Inc.
|
7,055 | $1,775,319 | |
| 5 | AMGN |
Amgen Inc
|
3,021 | $1,093,963 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
6,923 | $874,651 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
11,930 | $687,405 | |
| 8 | NVS |
Novartis AG
|
4,070 | $637,849 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $874,651 | 6,923 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $945,487 | 6,792 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $830,581 | 6,767 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $738,594 | 6,654 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $755,579 | 6,815 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $739,978 | 6,604 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $502,862 | 5,444 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $420,709 | 5,018 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $308,882 | 4,502 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $168,328 | 2,298 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $160,075 | 1,976 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $148,456 | 1,981 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $139,265 | 1,807 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $176,228 | 2,124 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $173,588 | 2,022 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $145,032 | 2,351 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $144,263 | 2,334 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $90,126 | 1,516 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $125,905 | 1,734 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $110,502 | 1,582 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $84,078 | 1,221 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $70,317 | 1,088 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $62,687 | 1,076 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $67,170 | 1,063 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $80,940 | 1,052 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $77,899 | 1,042 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||